University of Hong Kong

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

Retrieved on: 
Wednesday, March 27, 2024
Multiple, Professor, ETV, SAN, Patient, Hepatology, Southern Medical University, SHBG, Doctor of Science, University, Doctor of Philosophy, MBBS, MASH, MBA, Science, Therapy, Hepatitis, Part, Division, University of Hong Kong, Infection, CHB, Pharmaceutical industry

The poster presentation highlights ALG-055009 Phase 1 data that showed multiple-ascending doses (MAD) over 14 days in hyperlipidemic subjects produced favorable, dose-dependent pharmacodynamic effects on atherogenic lipids and sex hormone binding globulin (SHBG), an indicator of target engagement in the liver.

Key Points: 
  • The poster presentation highlights ALG-055009 Phase 1 data that showed multiple-ascending doses (MAD) over 14 days in hyperlipidemic subjects produced favorable, dose-dependent pharmacodynamic effects on atherogenic lipids and sex hormone binding globulin (SHBG), an indicator of target engagement in the liver.
  • “We are pleased to present these additional Phase 1 data for ALG-055009 and ALG-000184 at APASL 2024.
  • We continue to believe our molecule has the potential to be best-in-class,” said Lawrence Blatt, Ph.D., MBA, Chairman, President, and Chief Executive Officer at Aligos Therapeutics.
  • “In addition, the three ALG-000184 oral presentations demonstrate a consistent effect in the reduction of key viral markers.

Agilis Robotics Unveils Groundbreaking Advancements in Endoluminal Surgery

Retrieved on: 
Monday, February 5, 2024
Multimedia, Surgeon, Cystoscopy, Robotics, University, CFO, Chapter, System, Patient, Safety, National Medical Products Administration, FDA, Food, NMPA, University of Hong Kong, Food and Drug Administration, Bladder cancer, Learning curve, Gastrointestinal cancer, HKEX, Hospital, Pharmaceutical industry

HONG KONG, Feb. 2, 2024 /PRNewswire/ -- Agilis Robotics, a leading innovator in surgical robotics, is spearheading a paradigm shift in the field of "incisionless" endoluminal surgery.

Key Points: 
  • HONG KONG, Feb. 2, 2024 /PRNewswire/ -- Agilis Robotics, a leading innovator in surgical robotics, is spearheading a paradigm shift in the field of "incisionless" endoluminal surgery.
  • The robotic instruments offer unprecedented possibilities across endoluminal surgery, spanning the upper and lower gastrointestinal (GI) tract, urinary tract, throat, and gynaecology.
  • Agilis Robotics is a spin-off from The University of Hong Kong and has secured more than HKD 90 million in funding from private investors.
  • Furthermore, Agilis Robotics understands the importance of cost-effectiveness, marketability, and market potential, ensuring a successful venture for investors and hospitals.

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

Retrieved on: 
Thursday, November 9, 2023
Hepatology, Virology, Immune system, University of Hong Kong, AASLD, Patient, HBV, Clinical trial, Division, Non-cirrhotic portal fibrosis, Liver, University, Cancer, Autoimmunity, CFBV, Vaccine, Pharmaceutical industry, HBsAg, Gastroenterology

WARMINSTER, Pa. and OXFORD, United Kingdom, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a cure for people with chronic hepatitis B virus (cHBV) infection, and Barinthus Biotherapeutics plc (Nasdaq: BRNS), formerly Vaccitech plc, a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer, today announced a late breaking poster presentation at The American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting® 2023. The poster contains preliminary data from the Phase 2a clinical trial (AB-729-202) combining Arbutus’ RNAi therapeutic, imdusiran (AB-729), with Barinthus Bio's T-cell stimulating immunotherapeutic, VTP-300, and standard-of-care nucleos(t)ide analogue (NA) therapy.

Key Points: 
  • The poster contains preliminary data from the Phase 2a clinical trial (AB-729-202) combining Arbutus’ RNAi therapeutic, imdusiran (AB-729), with Barinthus Bio's T-cell stimulating immunotherapeutic, VTP-300, and standard-of-care nucleos(t)ide analogue (NA) therapy.
  • Preliminary immunology data suggests HBV-specific T cell IFN-γ production is enhanced in patients receiving imdusiran plus VTP-300 compared to placebo.
  • The preliminary safety data from this trial demonstrate that imdusiran and VTP-300 were both safe and well-tolerated.
  • Dr. Karen Sims, Chief Medical Officer of Arbutus Biopharma, commented, “Imdusiran consistently delivers compelling efficacy and safety data in multiple Phase 2a populations and combinations.

Alipay+ and Partner E-Wallets Drive Sustainable Travel in Year-End Global Campaign

Retrieved on: 
Thursday, December 14, 2023
Retail, Technology, Finance, Fintech, Other Travel, Transportation, Apps, Applications, Professional Services, Destinations, Travel, Other Retail, Personal Finance, Vacation, Payments, Mobile, Wireless, King Power, Sustainable Development Goals, Mom, GCash, Tourism, Somatosensory system, Chinese, BNPL, CUHK, Multimedia, Culture, University of Geneva, Ecosystem, SME, TrueMoney, Marketing, Merchant services, Digital, Tsinghua University, University, DAT, TPV, HK, Naukri.com, KakaoPay, Northwestern University in Qatar, ESG, Cryptocurrency, Online shopping, Tutoring, Alipay, University of Hong Kong

Ant International is committed to promoting sustainable and responsible tourism across its Alipay+ markets, with an ESG program closely aligned with the UN Sustainable Development Goals (SDGs).

Key Points: 
  • Ant International is committed to promoting sustainable and responsible tourism across its Alipay+ markets, with an ESG program closely aligned with the UN Sustainable Development Goals (SDGs).
  • The campaign features special offers from Alipay+ and partners to encourage sustainable travel behavior, such as free overseas mobile data packages, in-app discounts across Alipay+’s extensive merchant network, and opportunities to win 100% rebates at partner stores.
  • Dr Cherry Huang, General Manager of Alipay+ Offline Merchant Services, Ant International said, “Our year-end campaign is not just about travel; it’s about making a positive impact.
  • Touch ’n Go eWallet cross-border payments in the Chinese mainland have grown by more than 100% month-on-month in 2023.

Reimagining education: 2023 Yidan Prize Summit explores innovative ideas that spark change

Retrieved on: 
Tuesday, December 5, 2023
World Bank, Research fellow, Sustainable Development Goals, Research, Social change, Employment, Education, Head, Micki, Verdea (grape), University, UN, Intersectionality, Government, Yidan Prize, Student, Heart, University of Hong Kong, Teaching, University of the People, Teachers College, Columbia University, Arizona State University, Partnership, Sustainable Development Goal 4, Parent, Columbia University, Tutoring, Management, Science

HONG KONG, Dec. 5, 2023 /PRNewswire/ -- The Yidan Prize Foundation, the global philanthropic foundation behind the world's highest education accolade, hosted its highly anticipated Yidan Prize Summit in Hong Kong on 4 December, under the theme of "Ideas that spark change: a spotlight on solutions advancing education".

Key Points: 
  • HONG KONG, Dec. 5, 2023 /PRNewswire/ -- The Yidan Prize Foundation, the global philanthropic foundation behind the world's highest education accolade, hosted its highly anticipated Yidan Prize Summit in Hong Kong on 4 December, under the theme of "Ideas that spark change: a spotlight on solutions advancing education".
  • Dr Charles CHEN Yidan, Founder of the Yidan Prize, welcomed guests from around the world, emphasizing that ideas can spark change.
  • On 3 December, Professor Michelene Chi and Shai Reshef were formally awarded the 2023 Yidan Prize for Education Research and the 2023 Yidan Prize for Education Development respectively at the Yidan Prize Awards Ceremony.
  • They join the Yidan Prize Foundation's global community of education changemakers and the Yidan Council of Luminaries.

Reimagining education: 2023 Yidan Prize Summit explores innovative ideas that spark change

Retrieved on: 
Tuesday, December 5, 2023
World Bank, Research fellow, Sustainable Development Goals, Research, Social change, Employment, Education, Head, Micki, Verdea (grape), University, UN, Intersectionality, Government, Yidan Prize, Student, Heart, University of Hong Kong, Teaching, University of the People, Teachers College, Columbia University, Arizona State University, Partnership, Sustainable Development Goal 4, Parent, Columbia University, Tutoring, Management, Science

HONG KONG, Dec. 5, 2023 /PRNewswire/ -- The Yidan Prize Foundation, the global philanthropic foundation behind the world's highest education accolade, hosted its highly anticipated Yidan Prize Summit in Hong Kong on 4 December, under the theme of "Ideas that spark change: a spotlight on solutions advancing education".

Key Points: 
  • HONG KONG, Dec. 5, 2023 /PRNewswire/ -- The Yidan Prize Foundation, the global philanthropic foundation behind the world's highest education accolade, hosted its highly anticipated Yidan Prize Summit in Hong Kong on 4 December, under the theme of "Ideas that spark change: a spotlight on solutions advancing education".
  • Dr Charles CHEN Yidan, Founder of the Yidan Prize, welcomed guests from around the world, emphasizing that ideas can spark change.
  • On 3 December, Professor Michelene Chi and Shai Reshef were formally awarded the 2023 Yidan Prize for Education Research and the 2023 Yidan Prize for Education Development respectively at the Yidan Prize Awards Ceremony.
  • They join the Yidan Prize Foundation's global community of education changemakers and the Yidan Council of Luminaries.

Top AI experts share insights at HKUST-Greater Bay Area Association of Academicians symposium

Retrieved on: 
Tuesday, November 28, 2023
Cloud, Fireside chats, Research, Intelligence cycle, Hong Kong Polytechnic University, City University, Education University, Imagination, ByteDance, Student, Culture, Artificial intelligence, Turing Award, Policy address, University of Hong Kong, Renaissance, HKUST, Lingnan University, University, Speech, ChatGPT, Columbia University, AI, Hong Kong Baptist University, Innovation, Knowledge, LLM, Science, Life, I&T, Policy, Tutoring, Dairy, Medical device, Hong Kong

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- Top artificial intelligence (AI) experts, scholars and industry leaders from around the world have converged at a symposium in Hong Kong recently to share their knowledge, research and insights of ways to tap the potential of AI to improve the life of humankind.

Key Points: 
  • It will take years or decades for the development of artificial intelligence (AI) to reach human-level AI.
  • These are among the thought-provoking insights that Turing Prize winner Prof. Yann LeCun, hailed by the media as one of the "Godfathers of AI", elaborated in the symposium as a keynote speaker.
  • Entitled AI NEW HORIZONS 2023: A Symposium with Scientific Leaders, the event was jointly hosted by the Hong Kong University of Science and Technology (HKUST) and the Greater Bay Area Association of Academicians (GBAAA).
  • AI, Prof. LeCun said, will become a "shared infrastructure" in the future, like the Internet today.

Top AI experts share insights at HKUST-Greater Bay Area Association of Academicians symposium

Retrieved on: 
Tuesday, November 28, 2023
Cloud, Fireside chats, Research, Intelligence cycle, Hong Kong Polytechnic University, City University, Education University, Imagination, ByteDance, Student, Culture, Artificial intelligence, Turing Award, Policy address, University of Hong Kong, Renaissance, HKUST, Lingnan University, University, Speech, ChatGPT, Columbia University, AI, Hong Kong Baptist University, Innovation, Knowledge, LLM, Science, Life, I&T, Policy, Tutoring, Dairy, Medical device, Hong Kong

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- Top artificial intelligence (AI) experts, scholars and industry leaders from around the world have converged at a symposium in Hong Kong recently to share their knowledge, research and insights of ways to tap the potential of AI to improve the life of humankind.

Key Points: 
  • It will take years or decades for the development of artificial intelligence (AI) to reach human-level AI.
  • These are among the thought-provoking insights that Turing Prize winner Prof. Yann LeCun, hailed by the media as one of the "Godfathers of AI", elaborated in the symposium as a keynote speaker.
  • Entitled AI NEW HORIZONS 2023: A Symposium with Scientific Leaders, the event was jointly hosted by the Hong Kong University of Science and Technology (HKUST) and the Greater Bay Area Association of Academicians (GBAAA).
  • AI, Prof. LeCun said, will become a "shared infrastructure" in the future, like the Internet today.

XtalPi and HKU's Advanced Biomedical Instrumentation Centre Sign MoU to Accelerate Deep Tech Commercialization

Retrieved on: 
Monday, November 27, 2023
Research, Organization, IP, University, Applied science, Mallinckrodt, Artificial intelligence, Physics, University of Hong Kong, Health, HKU, Memorandum of understanding, Partnership, Doctor of Philosophy, AI, Harvard University, Robotics, ABIC, Mechanical, MOU, Tutoring, Hong Kong, Engineering

CAMBRIDGE, Mass., Nov. 27, 2023 /PRNewswire/ -- XtalPi Inc. (XtalPi) and the Advanced Biomedical Instrumentation Centre (ABIC or the Centre) at the University of Hong Kong (HKU) have entered a memorandum of understanding (MoU) that outlines a roadmap for scientific collaboration and commercialization of deep tech developed by ABIC researchers located both in Hong Kong and globally.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 27, 2023 /PRNewswire/ -- XtalPi Inc. (XtalPi) and the Advanced Biomedical Instrumentation Centre (ABIC or the Centre) at the University of Hong Kong (HKU) have entered a memorandum of understanding (MoU) that outlines a roadmap for scientific collaboration and commercialization of deep tech developed by ABIC researchers located both in Hong Kong and globally.
  • XtalPi's global team will lead commercial endeavors of selected ABIC technologies, while also promoting knowledge exchange with ABIC researchers regarding product development and commercialization.
  • We eagerly anticipate a close collaboration with XtalPi to transition groundbreaking scientific research into tangible industrial applications."
  • Dr. Wen also remarked, "XtalPi has an unwavering belief that Hong Kong will remain a crucial hub in the biotech industry.

The Shaw Prize Award Presentation Ceremony 2023: Celebrating 20 Years of Scientific Accomplishments

Retrieved on: 
Wednesday, November 15, 2023
Prize, Mathematical sciences, Hope, Convention center, University, Shaw Prize, Laureate, Shing-Tung Yau, University of Hong Kong, Exhibition, Speech, Government, Hong Kong Science Museum, Tutoring, Medicine, Astronomy, Hong Kong

HONG KONG, Nov. 15, 2023 /PRNewswire/ -- The Shaw Prize celebrated its 20th anniversary with a grand ceremony at the Hong Kong Convention and Exhibition Centre on 12 November.

Key Points: 
  • HONG KONG, Nov. 15, 2023 /PRNewswire/ -- The Shaw Prize celebrated its 20th anniversary with a grand ceremony at the Hong Kong Convention and Exhibition Centre on 12 November.
  • Dr Raymond Chan, Chair of the Shaw Prize Foundation, extended a warm welcome to the Laureates and guests in his opening speech.
  • He paid tribute to the remarkable contributions of the late Mr Run Run Shaw, founder of the Shaw Prize, and Mrs Mona Shaw, to the art, cultural, and educational development of Hong Kong and mainland China.
  • Dr Chan reiterated the Shaw Prize's mission is to celebrate scientific accomplishments that transcend geographical boundaries and expressed the hope that the Prize would contribute to making the world a better place.